These disclosures are from 13Ds filed with the Securities and Exchange Commission. 13Ds are filed within 10 days of an entity's attaining more than 5% in any class of a company's securities. Subsequent changes in holdings or intentions must be reported in amended filings. This material is from April 2 through April 8, 2026. Source: VerityData
Original Filings
Alkami Technology$(ALKT)$ Jana Partners Management disclosed a new position in the digital banking software company of 5,431,388 shares. Jana purchased 536,723 Alkami Technology shares from Feb. 26 through March 25 at per share prices ranging from $14.96 to $16.08. Following the latest purchases, Jana owns an initial 5.1% stake in Alkami Technology's outstanding stock. Shares of Alkami Technology have lost roughly 27.5% of their value in 2026.
Colliers International Group $(CIGI)$ Spruce House Investment Management disclosed a new position in the real estate services company of 2,552,883 shares. Spruce House purchased 1,209,867 of those shares from Feb. 25 through March 31 at per share prices ranging from $99.33 to $119.08. Following the latest purchases, Spruce House owns an initial 5.1% stake in Colliers International's outstanding stock. Shares of Colliers International have lost roughly 24.3% of their value in 2026
Decreases in Holdings
MoonLake Immunotherapeutics (MLTX) BVF Partners lowered its stake in the clinical-stage biotechnology company to 16,001,284 shares. BVF Partners did so through the sale of 3,750,000 MoonLake Immunotherapeutics shares on March 31 at a price of $16.79 per share. Following the latest sales, BVF Partners continues to own a 22.3% stake in MoonLake's outstanding stock. Shares of MoonLake have gained roughly 56.3% in value in 2026.
BridgeBio Pharma (BBIO) Viking Global Investors reduced its stake in the biotechnology company to 11,842,434 shares. Viking Global did so through the sale of 1,183,933 BridgeBio Pharma shares from Feb. 18 through Feb. 23 at per share prices ranging from $67.10 to $76.48. Following the latest sales, Viking Global continues to own a 6.1% stake in BridgeBio Pharma's outstanding stock. Shares of BridgeBio Pharma have lost about 5.3% of their value in 2026.
Southwest Airlines$(LUV)$ Elliott Management lowered its stake in the airline to 24,308,000 shares. Elliott Management did so through the sale of 10,367,000 Southwest Airlines shares from Feb. 24 through April 2 at per share prices ranging from $37.60 to $51.33. Following the latest sales, Elliott Management continues to own a 4.9% stake in Southwest's outstanding stock, placing Elliott below the 5% threshold that would require it to report further sales. Shares of Southwest have lost roughly 2.2% of their value in 2026
Cogent Biosciences(COGT) Fairmount Funds Management lowered its stake in the biotechnology company to 15,356,918 shares. Fairmount Funds did so through the sale of seven million Cogent Biosciences shares through a block trade on March 31 at a price of $34.66 per share. Following the latest sale, Fairmount Funds continues to own an 8.6% stake in Cogent Biosciences' outstanding stock. Shares of Cogent Biosciences have gained roughly 6.4% in value in 2026.
Email: editors@barrons.com
This content was created by Barron's, which is operated by Dow Jones & Co. Barron's is published independently from Dow Jones Newswires and The Wall Street Journal.
(END) Dow Jones Newswires
April 10, 2026 17:28 ET (21:28 GMT)
Copyright (c) 2026 Dow Jones & Company, Inc.